BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29499348)

  • 1. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
    Thabet Y; Lunter D; Breitkreutz J
    Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous inkjet printing of enalapril maleate onto orodispersible film formulations.
    Thabet Y; Lunter D; Breitkreutz J
    Int J Pharm; 2018 Jul; 546(1-2):180-187. PubMed ID: 29753906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From 'fixed dose combinations' to 'a dynamic dose combiner': 3D printed bi-layer antihypertensive tablets.
    Sadia M; Isreb A; Abbadi I; Isreb M; Aziz D; Selo A; Timmins P; Alhnan MA
    Eur J Pharm Sci; 2018 Oct; 123():484-494. PubMed ID: 30041029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased drug load and polymer compatibility of bilayered orodispersible films.
    Carolina Visser J; Weggemans OAF; Boosman RJ; Loos KU; Frijlink HW; Woerdenbag HJ
    Eur J Pharm Sci; 2017 Sep; 107():183-190. PubMed ID: 28709911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orodispersible films: Product transfer from lab-scale to continuous manufacturing.
    Thabet Y; Breitkreutz J
    Int J Pharm; 2018 Jan; 535(1-2):285-292. PubMed ID: 29146537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
    Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
    Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the effect of formulation variables on the characteristics of combination tablets containing enalapril maleate and indapamide as active substances using experimental design.
    Szabó ZI; Székely-Szentmiklósi B; Deák B; Székely-Szentmiklósi I; Kovács B; Zöldi K; Sipos E
    Acta Pharm; 2016 Jun; 66(2):191-206. PubMed ID: 27279063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
    Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
    AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-printing by flexographic printing technology--a new manufacturing process for orodispersible films.
    Janssen EM; Schliephacke R; Breitenbach A; Breitkreutz J
    Int J Pharm; 2013 Jan; 441(1-2):818-25. PubMed ID: 23266759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
    Speer I; Lenhart V; Preis M; Breitkreutz J
    Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide.
    Woertz C; Kleinebudde P
    Eur J Pharm Biopharm; 2015 Aug; 94():52-63. PubMed ID: 25976316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jet dispensing of multi-layered films for the co-delivery of three antihypertensive agents.
    Scoutaris N; Malamatari M; Letellier A; Douroumis D
    Drug Deliv Transl Res; 2018 Feb; 8(1):32-42. PubMed ID: 28967043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
    Speer I; Preis M; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOFTs - Structured orodispersible film templates.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Biopharm; 2019 Apr; 137():209-217. PubMed ID: 30836181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.
    Shamma R; Elkasabgy N
    Drug Deliv; 2016; 23(2):489-99. PubMed ID: 24892631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on disintegration methods for oral film preparations.
    Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
    Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization and in vitro evaluation of a polyvinyl alcohol/sodium alginate based orodispersible film containing sildenafil citrate.
    Shi LL; Xu WJ; Cao QR; Yang M; Cui JH
    Pharmazie; 2014 May; 69(5):327-34. PubMed ID: 24855822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key acceptability attributes of orodispersible films.
    Scarpa M; Paudel A; Kloprogge F; Hsiao WK; Bresciani M; Gaisford S; Orlu M
    Eur J Pharm Biopharm; 2018 Apr; 125():131-140. PubMed ID: 29355687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible and precise dosing of enalapril maleate for all paediatric age groups utilizing orodispersible minitablets.
    Thabet Y; Walsh J; Breitkreutz J
    Int J Pharm; 2018 Apr; 541(1-2):136-142. PubMed ID: 29474896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.